Coconut Creek, FL, Apr 12, 2019 - (ACN Newswire) - via NewMediaWire -- NutraLife Biosciences, Inc. announces that its wholly-owned subsidiary, PhytoChem Technologies, Inc., has entered into a joint venture with Henning Trading LLC. NutraLife and Henning plan to cultivate, harvest and process hemp, initially in Wisconsin for the 2019 grow season. NutraLife recently announced that it had received licenses from the state of Wisconsin to grow and process hemp.
NutraLife's joint venture with Henning Trading will be under the direction of NutraLife's Chief Executive Officer and President, Edgar Ward, and Henning's President, John Henning Jr., its Chief Operating Officer, Adam Bilbrey and its sales director, Michael Ward. Henning and PhytoChem plan to pursue opportunities for the cultivation, harvesting, processing and distribution of high-quality bulk and raw bulk material supply of Phytocannabinoid CBD rich hemp finished goods. In addition, NutraLife and Henning Trading will explore participation in the hemp seed propagation, fiber and grain markets.
"We are pleased to have finalized our agreement with Henning Trading and look forward to working with John Henning and Adam Bilbrey to pursue the Company's vertical positioning within the Hemp industry. We look forward to continued growth and new opportunities in the Nutraceutical, Hemp and Life Sciences markets as we enter the second quarter of 2019," said Edgar Ward, CEO and Founder of NutraLife.
About NutraLife BioSciences
NutraLife was founded by Edgar Ward in 2010 as NutraFuels, Inc. and since that time he has served as its Chief Executive Officer, President and Director. Under Mr. Ward's direction, NutraLife's revenues increased from $225,000 in 2016 to more than $3.7 million in 2018. NutraLife's Coconut Creek manufacturing facility has been registered with the Food and Drug Administration, operating in accordance with the Good Manufacturing Processes Standard (GMP) for more than five years. NutraLife's products are tested by its in-house laboratory chemists for strength, purity and contaminants such as heavy metals, pesticides, and solvents. NutraLife offers thirteen different core formulations which it modifies to meet the specifications of its private label customers, and approximately 50 different variations of these core formulations. NutraLife's private label products include CBD infused oral sprays, tinctures, pet drops, pain balms, face creams, and nutraceutical oral spray products for sleep support and weight loss packaged under the customer's brand names.
About Henning Trading LLC
Henning Trading LLC ("Henning Trading" or "Henning") was founded in 2018 by John Henning Jr. and Adam Bilbrey. Henning was founded to provide logistics, sourcing and extraction production for industrial hemp.
John Henning, Jr. is a graduate from the University of Mississippi with a Bachelor of Science. John owns and operates Henning farm in Kingman, Kansas that has been in the Henning family for 4 generations. Using the experience and knowledge he gained from his family's farming operations, John entered the industrial hemp market focusing on growing methods and cultivation.
Adam Bilbrey is a co-founder and President of Rental Geek, Inc, a company that revolutionized the off-campus student real estate rental market. Adam is also a co-founder and active officer at Famous Vape, Inc and a co-founder and majority partner at iMed Delivered, Inc. Adam holds a Masters in Business Administration and a Bachelor of Science in Business from Kansas State University.
NutraLife BioSciences, Inc.
6601 Lyons Road, Suite L-6
Coconut Creek, FL 33073
This press release contains statements of a forward-looking nature about NutraLife BioSciences, Inc. (OTCQB: NLBS) and Henning Trading, LLC. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. There is no assurance that the Company's current expectations and projections are accurate or that the Company's plans to cultivate, harvest and process Hemp with Henning Trading will be successful. All forward-looking statements in this press release are based on information available to the Company on the date hereof. More detailed information about these risk factors are set forth in the Company's filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the Section entitled "Risk Factors," in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission on April 2, 2019. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.
Topic: Press release summary
Source: NutraLife Biosciences, Inc.
Sectors: Agritech, BioTech, Healthcare & Pharm
From the Asia Corporate News Network
Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|NutraLife Biosciences, Inc. Releated News|
|Apr 4, 2019 05:00 HKT/SGT|
|NutraLife Bioscience, Inc. Reports 2018 Year End Financial Results|
|Mar 25, 2019 05:00 HKT/SGT|
|NutraLife Biosciences Encouraged By CVS Health Corporation's Decision to Distribute CBD at 800 Stores in the U.S.|
|Mar 15, 2019 05:00 HKT/SGT|
|NutraLife Bioscience, Inc. Receives License to Grow and Process Industrial Hemp|
|Mar 13, 2019 05:00 HKT/SGT|
|NutraLife Biosciences, Inc. Receives Contract to Provide Its Technologies and Delivery System for Pharmaceutical Products by cGMP Pharmacy|
|Mar 1, 2019 21:00 HKT/SGT|
|NutraFuels, Inc. Explores New Delivery Systems with Pharmaceutical GMP Manufacturer|
|More news >>|